基于纳米载体的模式识别受体向作为一种创新策略,用于增强败血症治疗
Eman A Ismail1,2, Vincent O Nyandoro1,3, Calvin A Omolo1,4
1Discipline of Pharmaceutical Sciences, College of Health Sciences, University of KwaZulu-Natal, Durban, Private Bag X54001, South Africa.
Advanced healthcare materials
|July 2, 2025
概括
针对模式识别受体 (PRRs) 的纳米药物提供了对抗败血症的新方法. 这些纳米载体提供治疗药物和调节免疫反应,有望改善败血症治疗和器官损伤的结果.
科学领域:
- 免疫学 免疫学 免疫学
- 纳米医学是一种纳米医学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 败血症是一种危及生命的器官功能障碍,由免疫反应对感染的失调引起.
- 目前治疗败血症的药理疗法和纳米药物有限.
- 模式识别受体 (PRRs) 是免疫对感染反应的关键,是可行的治疗点.
研究的目的:
- 审查PRR向纳米载体用于败血症治疗的开发和应用.
- 评估纳米载体的有效性,这些纳米载体的向是托尔类受体 (TLRs) 和NOD类受体 (NLRs).
- 确定这些纳米药物的临床转化所面临的挑战和机会.
主要方法:
- 对治疗败血症的PRR向纳米载体研究的文献综述.
- 对纳米材料,免疫调节效应和毒症模型 (体外和体内) 的性能进行分析.
- 评估涉及抗生素和抗炎药物的治疗策略.
主要成果:
- 针对PRR的纳米载体可以通过抑制PRR-联结体相互作用来提供治疗药物和调节炎症.
- 研究表明,在各种体外和体外败血症模型中取得了有希望的结果.
- 纳米材料显示出有针对性传递和免疫调节的潜力.
结论:
- 针对PRR的纳米载体代表了对败血症和相关器官损伤的有希望的治疗策略.
- 需要进一步的研究和优化,以克服临床翻译方面的挑战.
- 这些纳米系统有可能改善败血症治疗结果.
相关概念视频
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...